Regulations Governing Rewards or Subsidies for Development of Chinese Medicine and Pharmacy Article 6
Juristic persons, organizations, departments, institutions or schools with one of the following circumstances may apply for subsidies:1. Engage in Chinese medicine and pharmacy clinical efficiency and evidence-based research; Chinese medicine and pharmacy theories, literature and classics research or Chinese medicine diagnostic criteria research to enhance the clinical application and development of Chinese medicine and pharmacy.2. Engage in the research or manufacture of new ingredients, new therapeutic combinations, new administration routes, new raw materials, new raw material parts, or new combinations of Chinese medicine products, and promote the development of Chinese medicine and pharmacy clinical trials or Chinese pharmaceutical manufacturing industry.3. Introduce novel technologies into the domestic Chinese medicine manufacturing processes or analytical methods, and improve Chinese pharmaceutical manufacturing or analysis technology.4. Cultivate Chinese medicinal plants domestically that are medicinal source or improve its cultivation technique, and in accordance with the relevant legal requirements to enhance the clinical application and development of Chinese medicine.The subsidy amount for each application is up to two million New Taiwan Dollars per year, which can be increased if necessary.
中文原文 中醫藥發展獎勵或補助辦法第6條
法人、團體、機關、機構或學校具有下列情形之一者，得申請補助：
一、從事中醫藥臨床療效實證研究、中醫藥理論及典籍研究或中醫診斷基準研究，有助於提升中醫藥臨床應用及發展。
二、從事研發或製造中藥之新成分、新療效複方、新使用途徑、新藥材、藥材新藥用部位或新複方，有助於提升中醫藥臨床試驗及中藥藥品製造產業發展。
三、引入新穎科技於國內中藥製程或分析檢驗方法，有助於改良中藥製造或檢驗技術。
四、於國內種植屬藥用基原或改良種植技術，且符合相關法規之中藥藥用植物，有助於中醫臨床醫療應用及發展。
每一申請案之補助金額，每年最高新臺幣二百萬元，必要時得酌增之。
一、從事中醫藥臨床療效實證研究、中醫藥理論及典籍研究或中醫診斷基準研究，有助於提升中醫藥臨床應用及發展。
二、從事研發或製造中藥之新成分、新療效複方、新使用途徑、新藥材、藥材新藥用部位或新複方，有助於提升中醫藥臨床試驗及中藥藥品製造產業發展。
三、引入新穎科技於國內中藥製程或分析檢驗方法，有助於改良中藥製造或檢驗技術。
四、於國內種植屬藥用基原或改良種植技術，且符合相關法規之中藥藥用植物，有助於中醫臨床醫療應用及發展。
每一申請案之補助金額，每年最高新臺幣二百萬元，必要時得酌增之。